150417-18-8 Usage
General Description
(R)-3-aminomethyl-2-BOC-3,4-dihydro-1H-isoquinoline is a compound that consists of an isoquinoline core with an aminomethyl and tert-butoxycarbonyl (BOC) functional groups attached. It is a chiral compound, with the (R)-enantiomer being the active form. (R)-3-AMINOMETHYL-2-BOC-3,4-DIHYDRO-1H-ISOQUINOLINE has potential applications in medicinal chemistry, particularly as a building block in the synthesis of pharmaceuticals and bioactive compounds. Its isoquinoline core also suggests potential for biological activity, as isoquinoline alkaloids are known to exhibit a wide range of pharmacological effects. The BOC protecting group can be removed under mild conditions to reveal the primary amine, making it a versatile precursor for the synthesis of various nitrogen-containing compounds. Overall, (R)-3-aminomethyl-2-BOC-3,4-dihydro-1H-isoquinoline is a valuable chemical resource with potential for diverse applications in drug discovery and chemical synthesis.
Check Digit Verification of cas no
The CAS Registry Mumber 150417-18-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,0,4,1 and 7 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 150417-18:
(8*1)+(7*5)+(6*0)+(5*4)+(4*1)+(3*7)+(2*1)+(1*8)=98
98 % 10 = 8
So 150417-18-8 is a valid CAS Registry Number.
150417-18-8Relevant articles and documents
NOVEL DIPEPTIDYL PEPTIDASE-IV INHIBITORS
-
Page/Page column 24-25, (2008/12/07)
The present invention relates to novel compounds exhibiting excellent inhibitory activity versus Dipeptidyl Peptidase-IV (DPP-IV), methods of preparing the same and pharmaceutical compositions containing the same as an active agent.
DPP-IV inhibitors
-
Page/Page column 18, (2010/02/14)
The invention relates to compounds of formula (I) wherein Z, R1-8, n, A1, X1 and X2 have the meaning as cited in the description and the claims. Said compounds are useful as DPP-IV inhibitors. The invention also
AZACYCLIC COMPOUNDS AS OREXIN RECEPTOR ANTAGONIST
-
Page 15, (2010/02/07)
This invention relates to compounds of formula (I) and their use as arexin antagonists.